Erin D Milligan Selected Research

Sciatic Neuropathy (Lesion of Sciatic Nerve)

1/2022	Peripherally administered cannabinoid receptor 2 (CB2R) agonists lose anti-allodynic effects in TRPV1 knockout mice, while intrathecal administration leads to anti-allodynia and reduced GFAP, CCL2 and TRPV1 expression in the dorsal spinal cord and DRG.
1/2019	Targeting the β2-integrin LFA-1, reduces adverse neuroimmune actions in neuropathic susceptibility caused by prenatal alcohol exposure.
12/2017	Prenatal alcohol exposure is a risk factor for adult neuropathic pain via aberrant neuroimmune function.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Erin D Milligan Research Topics

Disease

34	Pain (Aches) 01/2020 - 01/2003
28	Hyperalgesia 01/2022 - 12/2001
24	Neuralgia (Stump Neuralgia) 01/2022 - 02/2003
6	Inflammation (Inflammations) 10/2006 - 01/2004
4	Peripheral Nervous System Diseases (PNS Diseases) 12/2020 - 07/2007
3	Sciatic Neuropathy (Lesion of Sciatic Nerve) 01/2022 - 12/2017
3	Opioid-Related Disorders (Opiate Addiction) 01/2022 - 02/2007
2	Chronic Pain 01/2019 - 01/2008
1	Neuroinflammatory Diseases 01/2019
1	Gliosis 01/2019
1	Premature Birth (Birth, Premature) 01/2019
1	Peripheral Nerve Injuries 01/2019
1	Hypoxia (Hypoxemia) 01/2018
1	Ischemia 01/2018
1	Hypersensitivity (Allergy) 05/2012
1	Intractable Pain 01/2008

Drug/Important Bio-Agent (IBA)

30	CytokinesIBA 12/2020 - 01/2003
20	Interleukin-10 (Interleukin 10)IBA 12/2020 - 03/2004
10	Interleukin-1 (Interleukin 1)IBA 07/2007 - 02/2003
8	Proteins (Proteins, Gene)FDA Link 12/2020 - 04/2005
6	CannabinoidsIBA 01/2022 - 01/2008
6	DNA (Deoxyribonucleic Acid)IBA 01/2018 - 12/2006
6	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 05/2012 - 02/2003
5	Pharmaceutical PreparationsIBA 01/2019 - 02/2005
5	Interleukin-6 (Interleukin 6)IBA 07/2007 - 02/2003
4	salicylhydroxamic acid (SHAM)IBA 12/2020 - 11/2009
4	Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link 01/2019 - 08/2004
3	3- (1,1- dimethyl- heptyl)- 1- hydroxy- 9- methoxy- benzo(c)chromen- 6- oneIBA 01/2022 - 05/2012
3	Lymphocyte Function-Associated Antigen-1 (LFA-1)IBA 01/2020 - 01/2019
3	Analgesics (Analgesic Drugs)IBA 01/2008 - 08/2004
3	Interleukin-1beta (Interleukin 1 beta)IBA 07/2007 - 12/2003
3	Interleukin-1 Receptors (Interleukin 1 Receptor)IBA 07/2007 - 03/2004
2	AM 1241IBA 01/2022 - 03/2012
2	Cannabinoid Receptors (Cannabinoid Receptor)IBA 01/2022 - 01/2011
2	Messenger RNA (mRNA)IBA 01/2020 - 01/2018
2	ChemokinesIBA 01/2019 - 08/2004
2	Mannose (D-Mannose)IBA 01/2018 - 05/2014
2	Glycoproteins (Glycoprotein)IBA 05/2012 - 07/2007
2	MitogensIBA 03/2012 - 02/2003
2	Phosphotransferases (Kinase)IBA 03/2012 - 02/2003
2	Opioid Analgesics (Opioids)IBA 11/2007 - 02/2007
2	Morphine (MS Contin)FDA LinkGeneric 02/2007 - 08/2004
2	fluorocitrateIBA 10/2006 - 02/2003
2	Complement System Proteins (Complement)IBA 03/2005 - 07/2004
2	Snake Venoms (Snake Venom)IBA 09/2004 - 03/2004
2	VenomsIBA 09/2004 - 03/2004
2	CX3C Chemokine Receptor 1IBA 09/2004 - 08/2004
2	Chemokine CX3CL1IBA 09/2004 - 08/2004
2	Secretory Phospholipases A2IBA 09/2004 - 03/2004
2	Nitric Oxide (Nitrogen Monoxide)FDA Link 09/2004 - 03/2004
2	Neutralizing AntibodiesIBA 08/2004 - 03/2004
1	TRPV1 receptorIBA 01/2022
1	ElementsIBA 01/2022
1	CationsIBA 01/2022
1	Biomarkers (Surrogate Marker)IBA 01/2022
1	CalpainIBA 01/2019
1	antineoplaston A10 (A 10)IBA 01/2019
1	Peroxidase (Myeloperoxidase)IBA 01/2019
1	SpectrinIBA 01/2019
1	Transforming Growth Factors (Transforming Growth Factor)IBA 01/2019
1	Connexin 43 (Connexin43)IBA 01/2019
1	Interleukin-8B ReceptorsIBA 01/2019
1	Chemokine CXCL1IBA 01/2019
1	LipopolysaccharidesIBA 01/2018
1	Mannose ReceptorIBA 01/2018
1	LigandsIBA 01/2018
1	SaccharinIBA 12/2017
1	Liposomes (Liposome)IBA 06/2013
1	1,2- dioleoyloxy- 3- (trimethylammonium)propaneIBA 06/2013
1	Polylactic Acid-Polyglycolic Acid CopolymerIBA 11/2012
1	InterleukinsIBA 05/2012
1	Anti-Inflammatory Agents (Anti-Inflammatories)IBA 05/2012
1	EnzymesIBA 03/2012
1	Cannabinoid Receptor AgonistsIBA 03/2012
1	EndocannabinoidsIBA 03/2012
1	Monoacylglycerol LipasesIBA 03/2012
1	Polyethylene Glycols (Polyethylene Glycol)FDA LinkGeneric 06/2010
1	ZM 241385 (ZM241385)IBA 11/2009
1	Phenol (Carbolic Acid)FDA Link 11/2009
1	ATL 313IBA 11/2009
1	AntibodiesIBA 11/2009
1	Adenosine (Adenocard)FDA LinkGeneric 11/2009
1	2- (4- (2- carboxyethyl)phenethylamino)- 5'- N- ethylcarboxamidoadenosineIBA 11/2009
1	Antidepressive Agents (Antidepressants)IBA 01/2008
1	Anticonvulsants (Antiepileptic Drugs)IBA 01/2008
1	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 01/2008
1	Gabapentin (Neurontin)FDA LinkGeneric 01/2008
1	Paclitaxel (Taxol)FDA LinkGeneric 07/2007
1	Antineoplastic Agents (Antineoplastics)IBA 07/2007
1	Aligeron (AS 2)IBA 12/2006
1	PolyethyleneimineIBA 11/2006
1	PolymersIBA 11/2006

Therapy/Procedure

10	Therapeutics 01/2019 - 02/2005
5	Spinal Injections 11/2012 - 03/2005
3	Analgesia 02/2007 - 08/2004
2	Injections 07/2007 - 12/2003
2	Subcutaneous Injections 09/2004 - 03/2004
1	Sutures (Suture) 01/2019
1	Pain Management 01/2019
1	Intramuscular Injections 10/2006